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Abstract
Background: Early diagnosis and intervention for children with Fetal Alcohol Spectrum Disorder
(FASD) reduces the risk of developing a range of secondary social, emotional and behavioural
problems and provides an opportunity for prevention of further alcohol exposed pregnancies. The
objective of this study was to describe specialist clinical service provision for the diagnosis and
assessment of children exposed to alcohol in pregnancy.
Methods: Fetal Alcohol Spectrum Disorder (FASD) diagnostic clinics were identified through
literature and internet searches. Clinics were sent a questionnaire asking for information on the
clinic population, clinic staff, assessment process and other services provided.
Results: Questionnaires were completed for 34 clinics: 29 were in North America, 2 in Africa, 2
in Europe and 1 in South America. No clinics were identified in Asia or Australasia. There was a
variety of funding sources, services offered, clinic populations, staff and methods of assessment.
Thirty-three clinics had a multi-disciplinary team. In 32 clinics, at least one member of the team had
specialist training in assessment of FASD. Neurobehavioural assessment was completed in 32
clinics. Eleven clinics used more than one set of diagnostic criteria or an adaptation of published
criteria.
Conclusion: Diagnostic services are concentrated in North America. Most responding clinics are
using a multidisciplinary approach with neurobehavioural assessment as recommended in published
guidelines. Agreement on diagnostic criteria would enable comparison of clinical and research data,
and enhance FASD research particularly for intervention trials.
Background
The effects on the fetus of alcohol exposure in pregnancy
have been well described but barriers to diagnosis remain.
Fetal Alcohol Spectrum Disorder (FASD) includes Fetal
Alcohol Syndrome (FAS), alcohol-related neurodevelop-
mental disorder (ARND) and alcohol-related birth defects
(ARBD), and is said to affect 1% of all live births in the
United States of America (USA) [1]. Prevalence rates of
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Fetal Alcohol Syndrome (FAS) are reported to be between
0.06 [2] and 0.68 [3] per 1,000 live births in Australia and
0.5 and 2 per 1,000 live births in USA [1]. Higher preva-
lence rates have been reported in populations in Italy (3.7
to 7.4 per 1,000 children) [4], South Africa (68.0 to 89.2
per 1,000 children in Cape Province) [5] and some indig-
enous populations (Plains Indian: 9.0 per 1,000 live
births [1]; Indigenous Australians: 2.76 [6] to 4.7 [3] per
1,000 live births).
Fetal Alcohol Syndrome costs the USA US$3.6 billion per
year and the total lifetime cost for an individual with FAS
is estimated at US$2.9 million [7]. The costs of FAS
include health care, residential and support services,
developmental disability services, special education,
social services, adult vocational services and productivity
losses [7]. Much of this cost is attributable to the second-
ary disabilities of FAS including disrupted education, con-
tact with the law, mental health problems, alcohol and
drug misuse, inappropriate sexual behaviour and inability
to obtain and maintain employment and independent liv-
ing [8-10]. Early diagnosis of FASD may reduce the odds
of experiencing these adverse outcomes by two- to four-
fold [10].
Guidelines regarding the assessment of children with sus-
pected FASD have been published in the USA [11-14] and
Canada [15]. Recommended standards for assessment
include multidisciplinary teams who have specific train-
ing in assessing children exposed to alcohol in utero, can
assess the child's and family's strengths and needs, and
make appropriate referrals for further management. The
aim of our study was to conduct an international survey to
describe specialist dedicated clinical service provision for
the diagnosis and assessment of children with FASD; to
establish which countries have specialised services and
describe the models of service used; and compare clinical
practice in the services with the published recommenda-
tions for assessment of children exposed to alcohol in
utero.
Methods
Clinics which provided a dedicated specialist service for
the assessment of children exposed to alcohol in utero
were included in this study. Diagnostic and assessment
clinics were identified by searching four literature data-
bases: MEDLINE (1950 to 2006), CINAHL (1982 to
2006), EMBASE (1980 to 2006) and PsychINFO (1985 to
2006). The term "Fetal Alcohol Syndrome" was combined
with "Health Services" or "Diagnosis". The internet was
searched for diagnostic clinics and clinic evaluation
reports using the Google search engine. In countries in
which no clinic was identified in the initial search,
researchers identified through publications about FASD
or on the internet and organisations involved with people
with a FASD were contacted for information regarding
diagnostic services in their country.
A questionnaire was designed to collect data from identi-
fied clinics on: the clinic population (number of children
seen, age range, referral process); clinic staff (number,
professional group, specific training in diagnosis of FASD,
role in clinic); assessment process (number and length of
visits, assessment tools and diagnostic criteria used); and
other clinic activity (screening, management and
research). Contact details of other clinics known to
respondents were also sought. The questionnaire was a
structured, three page, self- administered instrument
which could be completed electronically or by hand. The
questionnaire was piloted as a structured telephone inter-
view prior to sending to all clinics. All contact with clinics
was via email. The questionnaire is available on request
from the authors.
Figure 1 shows the survey process. The questionnaire was
sent to identified clinics between June and December
2006 inclusive. When a network of clinics was identified,
the principal clinics in that network were contacted. Clin-
ics that did not respond were contacted up to 3 times and
if there was still no response the questionnaire was com-
pleted using published clinic evaluation reports when
available [16-19]. Clinics that were not specific FASD
diagnostic services (e.g. general dysmorphology or genetic
or child development clinics) were not eligible for inclu-
sion in this survey.
Results
Contact was made with clinics identified in the literature
search, research clinics linked to these, and potential clin-
ics identified after general enquiry. We had responses to
our enquiries stating that there was no identified specialist
FASD diagnostic service from Europe (Denmark, Finland,
France, The Netherlands, Norway, Russia, Spain, Sweden,
Switzerland, Ukraine); Asia (Japan) and Australasia (Aus-
tralia, New Zealand). No response was received from Bra-
zil and Germany. We received 20 completed
questionnaires from eligible clinics and completed ques-
tionnaires for 14 further clinics using published evalua-
tion reports identified in the search (Figure 1). Of the 34
clinics, 24 clinics were from the USA, five from Canada
and five from outside North America (United Kingdom,
Italy, Chile, South Africa) (Table 1). The completed ques-
tionnaires included one group of three linked research
clinics in the USA, South Africa and Italy, which were
included as separate clinics. Two additional clinics in the
USA had external research clinics. However, there was
insufficient information for inclusion of these sites as sep-
arate clinics. Aggregate data was available on one state
clinic network in the USA but individual clinic data was
not available for the eleven teams within the network.BMC Pediatrics 2008, 8:12 http://www.biomedcentral.com/1471-2431/8/12
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Clinics had a variety of funding sources, services offered,
clinic populations, staff and methods of assessment
(Table 1). Funding came from many sources, including
charitable and community sources in four cases. One
clinic had closed because of lack of funding and seven
were funded by research grants. Four of the five clinics
outside North America were funded partially or wholly by
research grants from the USA. Only two clinics, both in
the USA, relied wholly on patient fees (self-pay or insur-
ance) and did not receive any state, federal, research or
charitable contributions.
All 34 clinics offered a diagnostic service. Sixteen were also
involved in screening for at risk children; 15 offered short
term management; and nine offered ongoing manage-
ment (Table 1). Thirty-one clinics offered training to
external health professionals and 11 provided training for
parents. Twelve clinics provided outreach services, 10 pro-
vided case conferencing, six provided home visits, and
one provided a telemedicine service.
Referral criteria varied between clinics (Table 1). Eight of
the 34 clinics had no specific referral criteria. Of the clinics
with referral criteria, some required only a history of pre-
natal alcohol exposure, whereas others had more specific
criteria mirroring the diagnostic features of FAS (i.e. pre-
natal alcohol exposure, central nervous system disorder
and growth deficiency). Most clinics (n = 27) accepted
referrals from multiple sources. Primary care practitioners
were the most common referral source (n = 27), followed
by specialist paediatricians (n = 24). Other common refer-
ral sources included self or family referral (n = 23), child
protection services (n = 23), mental health services (n =
22), schools (n = 21), legal services (n = 21), family sup-
port groups (n = 11), drug and alcohol services (n = 10),
other health professionals (n = 10) and geneticists (n = 8).
Five clinics with a research focus did not accept referrals
but specifically recruited children exposed to alcohol in
utero for assessment.
There were differences between the patient populations of
clinics (Table 1). The number of new patients seen in clin-
ics each year ranged from 20 to 1600. The rate of diagnosis
of FAS ranged from 0.7% to 45% (median 7.4%). The rate
of diagnosis of other FASD ranged from 2.5% to 100%
(median 25%). Twelve of the 17 clinics who provided
estimates of both FAS and other FASD rates in their clinic
population stated a higher rate of other FASD than FAS
diagnosis. An estimate of the ethnic composition of their
clinic population was provided by 18 clinics: 10 reported
seeing a majority of Caucasian children; three clinics
reported that children seen were most commonly of
indigenous origin. Twenty-four clinics reported that the
majority of children lived in alternate care (away from
their biological parents). In 20 of these clinics, 75% or
more of the children seen were in alternate care.
Survey process and response Figure 1
Survey process and response.
Literature search, internet search and email enquiries:
Potential specialist FASD clinics (n=42)
Included specialist FASD clinics (n=34; 81%)
Potential specialist FASD 
clinics with completed surveys 
(n=38; 90%)
Surveys completed for non-
responding clinics from published 
reports (n=14; 33%)
Response (n=24; 57%)
Excluded: not specialist FASD 
clinic (n=4; 10%)B
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Table 1: Clinic Characteristics
Clinic Site Funding Source Services Offered Training for 
Professionals
Training for 
Parents
Referral Criteria Ages Seen New referrals 
seen per year
% of Children seen 
with FAS/FASD
Canada
Province A13 State, fee for service Diagnosis, short term 
management
Yes NR None All ages 60 NR
Province B14 State, research, community Diagnosis, short term 
management
No No Children with verified prenatal exposure to alcohol selected from 
the waiting list for the Psychology Clinic
6 to 16 yrs 15 in pilot period NR
Province C Federal, charitable Screening, diagnosis, 
management
NR Yes Children of drug treatment programme only 0 to 6 yrs 50 to 75 NR
Province C16 Federal funding now ceased; 
clinic not operational
Diagnosis, short term 
management
Yes NR None 0 to 12 yrs 49 3/77
Province C State Screening, diagnosis, 
management
Yes Yes Prenatal alcohol exposure & evidence of CNS (behaviour) <18 yrs 40- to 50 Unknown, most would 
have ARND
USA
State Aa Federal Diagnosis, short term 
management
Yes No Pre-natal alcohol exposure Usually <18 years 150 across 
network
2.6/70
State B Self-pay, insurance Diagnosis Yes Yes None 0 to 12 yrs 35 10/90
State Bb Insurance, research grants Screening, diagnosis, 
management
Yes No None All ages 100 10/10
State B Fee for service Diagnosis Yes No None 0 to 21 yrs 50 25/25
State B State Screening, diagnosis Yes No Prenatal alcohol exposure and contacted telephone information 
service
All ages NR 1/5
State C State & federal funding, fee for 
service, insurance
Screening, diagnosis, 
management
Yes Yes Prenatal exposure to alcohol or other drugs 0 to 21 yrs 200 to 250 45/30
State Db Research grants Screening, diagnosis No No Children of heavy drinkers NR NR NR
State E Fee for service, charitable 
foundation
Diagnosis Yes No FASD highly suspected, but may not be confirmed. 0 to 21 yrs 80 5/87
State F State & federal Screening, diagnosis Yes Yes None 0 to 20 yrs 100 20/30
State Gc Federal Screening, diagnosis Yes NR Developmental delay, growth parameters < 25th centile, known 
prenatal alcohol exposure, or previous diagnosis of FAS/FASD
0 to 18 yrs 300 0.7/3.7
State H State & federal funding, fee for 
service
Screening, diagnosis, 
management
Yes Yes None All ages 300 to 400 10/15
State I Sliding fee scale, adoption 
subsidy, children services, 
contributions
Screening, diagnosis, 
management
Yes Yes Prenatal Alcohol exposure suspected then referrals screened for 
suitability
3 to 18 yrs 20 20/80
State J State Screening, diagnosis Yes Yes Any prenatal alcohol exposure All ages 60 families 9/vast majority
State K Contract, federal, state, fee for 
service
Screening, diagnosis, short 
term management
Yes Yes Prenatal alcohol exposure, developmental &/or behavioural 
concerns
3 to 16 yrs 24 5/95
Chile
Clinic A Research grants (US NIH) Screening, diagnosis, 
management
Yes Yes Protocol (unspecified) 0 to 5 yrs 20 8/25
South Africa
Clinic A Research grants (US and local) Screening, diagnosis, 
management
Yes Yes Birth records from local hospitals 9 to 24 months & 
7 to 12 yrs
Recruited, not 
referred
Multiple sites, range: 
1.9 to 10.3/2.5 to 12.2
Clinic Bc Federal (US Research) Screening, diagnosis, 
management
Yes NR Developmental delay, growth parameters < 25th centile, known 
prenatal alcohol exposure, or previous diagnosis of FAS/FASD
0 to 18 yrs 1600 7.4/NR
Italy
Clinic Ac Federal (US Research) Screening, diagnosis Yes NR Developmental delay, growth parameters <25th centile, known 
prenatal alcohol exposure, or previous diagnosis of FAS/FASD
0 to 18 yrs 543 4/NR
United Kingdom
Clinic A National Health Service Diagnosis Yes No None 14 to 18 yrs 12 (6 months only) 0/100
NR, no response to the question.
a Aggregate data for network of 11 clinics.
b These clinics also have research focussed satellite clinics, however insufficient separate information was given for separate inclusion.
c Clinics are a linked research network.BMC Pediatrics 2008, 8:12 http://www.biomedcentral.com/1471-2431/8/12
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Thirty-three of the 34 clinics were staffed by a multidisci-
plinary team; however the composition of teams varied
(Table 2). All 33 multidisciplinary teams had at least one
medical and one psychology professional. The one clinic
that was not run by a multidisciplinary team was staffed
by a dysmorphologist. At least one member of staff had
undergone specialist training for FASD in 32 clinics. In 22
clinics, all members of staff had undergone specialist
training.
For thirty clinics, information was available on their clin-
ical assessment process. Four clinics did not request any
information prior to the visit for assessment. Thirteen of
those that required prior information requested medical
assessment reports; 12 requested childcare, preschool or
school reports; 11 requested developmental or psycho-
metric assessments; nine requested Child Protection Serv-
ice or Foster Service records; and four clinics requested
birth records. The number of visits required for assess-
ment and diagnosis ranged from one to three with a
median of one visit. Two clinics responded that the
number varied from child to child. The duration of visits
was between 0.5 and 6 hours, with a median of 3.25 hours
Table 2: FASD Diagnostic Clinic Team Composition (n = 34)
Type of Staff Number of clinics
Number of clinics with any Psychology Professional 33
Psychologist 30
Neuropsychologist 10
Psychometrists 1
Number of clinics with any Medical Professional 34
General Paediatrician 21
Geneticist/Dysmorphologist 12
Developmental Paediatrician 8
Nurses 4
Child Psychiatrist 4
Physician 1
Paediatrician/Toxicologist 1
Endocrinologist 1
Ophthalmologist 1
Number of clinics with any Allied Health Professional 23
Occupational Therapist 23
Speech Therapist 23
Physiotherapist 14
Dietician 1
Audiologist 1
Number of clinics with any Family Support Professional 29
Social Worker 22
Mental Health Worker 14
Family/Follow up Support Worker (non-diagnostic) 13
Case Manager 9
Cultural Worker 5
Family Advocate 4
Drug and Alcohol Worker 2
Child Protection Worker 1
Genetic counsellor 1
Child Development Counsellors 1
Home based parent-child therapists 1
Number of clinics with any Education Professional 8
Licensed Educational Diagnostician 3
Teacher 3
Education Specialist 2
Number of clinics with any specified Administrative Support: 7
Clinic/Team Coordinator 7
General administrative support 2
Number of clinics with any additional Research Support Workers: 5
Maternal Interviewer 3
Research Assistant 1
Residents/post doctoral fellows/interns 1BMC Pediatrics 2008, 8:12 http://www.biomedcentral.com/1471-2431/8/12
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(16 of 23 responses gave a specific numerical duration for
each visit; others were either variable or age-specific).
The primary caregiver(s) and the child attended the assess-
ment in all 33 of the clinics for which we had information.
In three clinics, siblings also attended the assessment and
in one other clinic, siblings were invited to attend if
appropriate. Six clinics specified that case managers or
social service workers or child protection workers attend
the clinic. In fifteen clinics, all members of the multidisci-
plinary team took part in the diagnostic process. In two
clinics, the geneticist/dysmorphologist made the diagno-
sis alone, and in all other clinics more than one member
of the team took part in the diagnostic assessment process.
Clinics had different approaches to the assessment proc-
ess. Twenty-three reported that they routinely carried out
a physical assessment of the child. Twenty-five clinics took
facial photographs and seventeen clinics used facial anal-
ysis software. Other routine assessments included audiol-
ogy (n = 7), genetic testing (n = 7), vision assessment (n =
6) and neuro-imaging (n = 5). Thirty-two clinics carried
out some neurobehavioural assessment. One clinic did
not respond to this question, and one did not carry out
any neurobehavioural assessment. Neurobehavioural
assessments included: behavioural assessment (n = 28);
motor or visual-motor or perception tests (n = 28); sen-
sory function (n = 22); cognitive or developmental testing
(n = 19); neuropsychometric tests (n = 17); adaptive
behaviour or social skills or social communication (n =
17); communication assessment (n = 13); educational or
academic assessment (n = 12); and neurological examina-
tion (n = 12).
Information was sought on the diagnostic criteria clinics
used. Of the 23 clinics using one set of diagnostic criteria,
fourteen were using the Washington 4-digit Diagnostic
code (2004) [11], eight were using Hoyme et al's 2005
revision of the 1996 Institute of Medicine criteria [13],
one was using the 1996 Institute of Medicine's criteria
[14] and none were using the Center for Disease Control's
2004 guidelines [12]. Eleven of the 34 clinics used more
than one of the published criteria or an adaptation of pub-
lished criteria. Two of the clinics using the Washington 4-
digit Diagnostic code as their only diagnostic criteria had
made adaptations to it. Nine clinics were using a combi-
nation of criteria: Washington 4-digit Diagnostic code,
Center for Disease Control's 2004 guidelines and 1996
Institute of Medicine (n = 2); diagnostic blend of Hoyme
et al, Canadian guidelines, Washington 4-digit Diagnostic
code and 1996 Institute of Medicine (n = 1); Hoyme et al,
Washington 4-digit Diagnostic code and 1996 Institute of
Medicine (n = 1); Canadian guidelines and Washington 4-
digit Diagnostic code (n = 1); Washington 4-digit Diag-
nostic code and 1996 Institute of Medicine (n = 1);
Hoyme et al and 1996 Institute of Medicine (n = 1);
Center for Disease Control's 2004 guidelines and 1996
Institute of Medicine (n = 1); 1996 Institute of Medicine
and other criteria (n = 1).
Of the 34 clinics included in the survey, fifteen offered
short-term management and nine offered longer-term
management. Of the 24 clinics offering management to
their patients following diagnosis, a variety of interven-
tions were used. The most common intervention was pro-
vision of family support services (n = 10). Other
management offered included counselling or behaviour
management (n = 6), speech therapy (n = 5), case man-
agement (n = 4), physiotherapy (n = 4), occupational
therapy (n = 4), child and adolescent mental health serv-
ices (n = 4), and drug and alcohol (n = 3). For clinics that
did not offer management (n = 10), referrals for follow up
care and management were made to local services (n = 2),
state services (n = 1), to the school district (n = 2) or back
to the primary care practitioner (n = 1).
Conclusion
Despite evidence that early diagnosis and intervention
may be beneficial to children with FASD [10], specialist
diagnostic clinics for FASD are largely limited to North
America. All but one of the diagnostic clinics found out-
side North America were research based and funded either
partially or wholly by research grants from the USA.
In regions which lacked specialist clinics, particularly
Europe, there was interest and work towards establishing
diagnostic and assessment services.
Making a diagnosis of the conditions resulting from alco-
hol exposure in utero can be difficult for an untrained
health professional. Many of the features of these condi-
tions can be seen in a number of other genetic and malfor-
mation syndromes, and it can often be hard to ascertain
pre-natal exposure to alcohol use [12]. The diagnosis of
ARND can be particularly challenging due to the absence
of physical signs. Thirty-two of the clinics stated that at
least some members of the diagnostic team had under-
gone specialist diagnostic training.
Surveys of child health professionals demonstrate their
lack of knowledge about the diagnostic features of FAS
[20-23]. American studies indicate good general knowl-
edge about FAS but hesitancy to make a diagnosis [21,22].
Australian surveys demonstrate a lesser knowledge of the
diagnostic features and a similar hesitancy to make a diag-
nosis [20,23]. These surveys also identify that health pro-
fessionals feel poorly equipped to manage a patient with
FAS [20-23]. Health professionals would like more
resources including information on FAS, referral servicesBMC Pediatrics 2008, 8:12 http://www.biomedcentral.com/1471-2431/8/12
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and a register of health professionals with expertise in
diagnosing FAS [20].
The diagnosis of a FASD is complicated by the debate
about the most appropriate diagnostic criteria, with mul-
tiple guidelines published since 1996 [11-15,24]. This
complexity was reflected in this survey. Notably, several
clinics used more than one set of diagnostic criteria or
their own adaptations of published criteria. The Center for
Disease Control's 2004 guidelines only define diagnostic
criteria for FAS [12]. Services which use these criteria
would need to use another set of diagnostic criteria for
other FASD diagnoses. Only two of the clinics using a
combination of criteria, were using the same combination
of criteria. This lack of agreement in diagnosis reduces the
potential for comparison of data about FASD across clin-
ics and countries. It also highlights the potential for con-
fusion for health professionals around the diagnosis of
FASD.
Of the 34 clinics, 33 were staffed by a multi-disciplinary
team. All the clinics with a multi-disciplinary team had
medical and psychology professionals but not all had
allied health professionals, family support services and
education professionals recommended in the literature
[12,15,25]. The clinics are generally using a multidiscipli-
nary approach with some form of neurobehavioural
assessment as recommended in published guidelines [11-
13,15,25].
There was a variety of ways of delivering the service to the
community. Some clinics were situated within the com-
munity for which it provided diagnosis and assessment.
Some clinics were based in large centres and provided out-
reach clinics to smaller centres, or, in one case, a telemed-
icine service. This survey was not designed to capture
diagnostic and assessment services provided within gen-
eral genetic, paediatric or child development clinics. How-
ever, we know that these clinics do see children exposed
to alcohol in utero, especially in areas without specialised
clinics. Training needs to be accessible to all health profes-
sionals who are in the position to identify children who
need assessment, as well as the health professionals who
are providing diagnosis and assessment.
Our study has limitations. A range of countries was repre-
sented in the study, but not every country where FASD has
been reported. Although we asked identified clinics,
researchers and FASD organisations for contacts details of
relevant services, our search strategy was biased towards
services which had the resources to develop a website or
publish research. This was more likely to exclude small
clinics and clinics in developing countries. All communi-
cation was made in English and by email which excluded
health professionals who do not read English or do not
have email and internet access. The response rate was dis-
appointing and only two respondents suggested other
clinics to contact, leading to significant gaps in the data.
There was a poor response rate from Canadian clinics
where there is a large amount of clinical activity. Data for
fourteen clinics was obtained only from published reports
i.e. they did not respond to the questionnaire. All these
factors affect the representativeness of the sample. The
question regarding the rate of FASD diagnoses was
intended to include children with a FASD diagnosis other
than FAS. However, the wording of the question was
ambiguous and thus some FASD rates may include FAS
while others do not. Interestingly, higher rates of all FASD
diagnoses in a clinic did not correspond with stricter refer-
ral criteria.
This study provides the first overview of the international
provision of specialist services for diagnosis and assess-
ment of children exposed to alcohol in utero. Specialist
diagnostic and assessment services are concentrated in
North America, and clinics outside North America are
mostly dependent on research funding from the USA.
Where specialist services do exist, there is a considerable
variation in diagnostic practice but there is strong support
for a multidisciplinary approach by trained professionals.
The variation in use and application of diagnostic criteria
is a key issue which needs to be further addressed by clini-
cians and researchers in this field to promote consistency
in diagnosis, and allow international comparison of clin-
ical and research data. This is particularly relevant for epi-
demiological studies and evaluation of specific
interventions for children with a FASD.
There is a range of possible models for the provision of
FASD assessment services for children including assess-
ment by: individual health professionals; general child
assessment services such as child development or genetic
services; or specialist FASD assessment services. Within
each of the models, there are several options, for instance:
type of health professional(s), assessment process and
diagnostic criteria. Planners need to assess the possible
models or mixture of models that would suit their context
and identify strategies to ensure funding, sufficient num-
bers of appropriately trained professionals and access for
dispersed populations. If a specialist assessment service
model is chosen, planners should consider using a multi-
disciplinary team and provision of specialist training in
FASD diagnosis and assessment for team members.
Whichever service model is used, health professionals
should be educated and supported to identify and provide
appropriate services to children exposed to alcohol in
utero. Finally, implementing consistent diagnostic criteria
will enable collaborative research and meaningful com-
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